Playback speed
10 seconds
Treatment Advances in Waldenström Macroglobulinemia
By
i3 Health
FEATURING
Morie Gertz
By
i3 Health
FEATURING
Morie Gertz
48 views
March 24, 2022
In this case-based discussion, Dr. Gertz discussed how to use predictive and prognostic markers to ...
read more ↘ select treatment for patients with Waldenstrom macroglobulinemia (WM) and how to appraise emerging clinical trial data and adverse event management strategies for novel treatments.
Since this live symposium, there have been several significant updates in the treatment and management of WM. Dr. Gertz recently sat down with Oncology Data Advisor again to discuss these updates and share all that has occurred in this evolving field.
Additional Advances in WM Research and Clinical Trials: https://bit.ly/3iZe2UX
Activity: https://bit.ly/3tMHsHk
Slide Deck: http://bit.ly/3VVQM8F
↖ read less
read more ↘ select treatment for patients with Waldenstrom macroglobulinemia (WM) and how to appraise emerging clinical trial data and adverse event management strategies for novel treatments.
Since this live symposium, there have been several significant updates in the treatment and management of WM. Dr. Gertz recently sat down with Oncology Data Advisor again to discuss these updates and share all that has occurred in this evolving field.
Additional Advances in WM Research and Clinical Trials: https://bit.ly/3iZe2UX
Activity: https://bit.ly/3tMHsHk
Slide Deck: http://bit.ly/3VVQM8F
↖ read less
Comments 0
Login to view comments.
Click here to Login
Videos
Getting Ahead of the ALS Curve: Exploring Disease-Modifying Therapies
i3 Health
S. Paganoni
29 views
Cracking the Code for Improved Patient Outcomes in Advanced Renal Ce…
i3 Health
E. Jonasch
220 views
MSKCC 2021 Update on Therapeutic Advances in T-Cell Lymphoma: Subtyp…
i3 Health
S. Horwitz
142 views
Optimizing the Management of Moderate-to-Severe Atopic Dermatitis in…
i3 Health
S. Feldman
186 views